Work

Survival Benefit of Universal Homologous Recombination Deficiency Testing in Ovarian Cancer Patients

Year: 2026

Type: preprint

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.6946280

Authors: Claudia L. Seguin, Andrew Eckel, Clare E. Wiberg, Ling Chen, Joel Agarwal, Jennifer S. Ferris, Alexi A. Wright, Mary Linton B. Peters, Amy B. Knudsen, Jason Wright, Pari V. Pandharipande

Institutions: Stanford University, Tufts University, Tufts Medical Center, Columbia University, Harvard University, Dana-Farber Cancer Institute, Massachusetts General Hospital

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7164933387

Cites:

Cited by:

Related to: